AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2016
Jun 23, 2016
35334_dirs_2016-06-23_3f59ea04-358b-42ce-9daf-e859289fd921.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2016-06-21
Reporting Person: MITCHELL WILLIAM M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-21 | Options to Buy Common Stock | $0.13 | A | 150000 | Acquired | 2026-06-21 | Common Stock (150000) | Direct |
More from AIM ImmunoTech Inc.
Governance Information
2026
Jun 10
Capital/Financing Update
2026
Jun 10
Capital/Financing Update
2026
Jun 8
Report Publication Announcement
2026
Jun 4
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 19
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14